CDER’s new proposal to withdraw the accelerated acceptance of Makena (HPC) was primarily based on a large randomized trial that failed to substantiate the benefit of this drug to newborns or lessen the chance of https://brontelcwm827792.wikilima.com/714322/mkena_an_overview